Acadia Healthcare Reports 7.6% Revenue Growth but Declines in Net Income for Q1 2026

Acadia Healthcare Company, Inc. reported a revenue increase of 7.6% for the first quarter of 2026, reaching $828.8 million compared to $770.5 million in the same period of 2025. The growth was driven by a rise in same facility revenue, which increased by 7.3%, attributed to a 6.5% increase in admissions and a 5.6% rise in revenue per patient day. However, net income attributable to Acadia decreased to $4.1 million, or $0.05 per diluted share, down from $8.4 million, or $0.09 per diluted share, in the prior year. The decline in profitability was influenced by higher operating expenses, including salaries, wages, and benefits, which rose to $467.0 million from $445.3 million.

The company's total expenses for the quarter were $817.8 million, up from $757.0 million a year earlier, with notable increases in legal settlements and transaction costs. Legal settlements expense surged to $13.8 million, primarily due to costs associated with ongoing litigation. Additionally, interest expense rose to $38.3 million, reflecting increased borrowings. The effective tax rate for the quarter was significantly higher at 59.3%, compared to 32.7% in the previous year, largely due to nondeductible executive compensation and valuation allowances against certain state deferred tax assets.

Acadia's operational metrics showed a slight increase in patient days by 1.6%, indicating stable demand for its services. The company operated 275 behavioral healthcare facilities with approximately 12,400 beds across 40 states and Puerto Rico as of March 31, 2026. During the quarter, Acadia added 82 beds, including expansions at existing facilities and the opening of new ones, while closing four facilities with a total of 251 beds. The company continues to focus on geographic expansion and enhancing its service offerings to meet the growing demand for behavioral healthcare.

In terms of financial position, Acadia reported total assets of $5.5 billion, a slight increase from $5.5 billion at the end of 2025. The company’s cash and cash equivalents rose to $158.5 million from $133.2 million, bolstered by improved cash flow from operations, which increased to $61.5 million compared to $11.5 million in the prior year. The company’s long-term debt stood at $2.5 billion, reflecting a modest increase from $2.47 billion at the end of 2025. Acadia remains in compliance with its financial covenants and has significant availability under its revolving credit facility.

Looking ahead, Acadia Healthcare is focused on leveraging its scale and operational expertise to navigate the challenges of a tight labor market and rising costs. The company aims to continue expanding its facilities and services while managing expenses effectively. However, it faces potential impacts from recent legislative changes affecting Medicaid funding and eligibility, which could influence its financial performance in the coming years.